You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
PROTON PUMP INHIBITOR-INDUCED SEVERE CUTANEOUS ADVERSE REACTION IN A MEDICAL CENTER
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Poster
- Poster code: POS-HPS-067
- By: LI, Chia Lin (China Taiwan)
- Co-author(s): Chia Lin Li: Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taiwan,
Li-Huei Chiang: Department of Clinical Pharmacy Service, Linkou Chang Gung Memorial Hospital, Taiwan,
Hui-Yu Chen: Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taiwan,
Tzu-Cheng Tsai: Department of Clinical Pharmacy Service, Linkou Chang Gung Memorial Hospital, Taiwan, ;Department of Long Term Care, Hsin Sheng College of Medical Care and Management, Taiwan,
Shin-Tarng Deng: Department of Pharmacy Administration, Linkou Chang Gung Memorial Hospital, Taiwan - Abstract:
Background
Proton pump inhibitors (PPIs) with the relatively safe profiles are widely used for treatment of acid-related diseases. However, severe cutaneous adverse reactions (SCARs) induced by PPI such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) are rarely reported.Methods
This was the cross-sectional study by analyzing.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026